Moreover, in AD, C3a and C3aR have been implicated in the disruption of the integrity of the blood–brain barrier (BBB) because binding of C3a to C3aR on BBB endothelial cells leads to calcium-mediated loss of intercellular junction proteins [43]. The gene discussed is C3; the disease is Alzheimer disease.